Document:

EXHIBIT 10.18

                          STRATEGIC ALLIANCE AGREEMENT

THIS STRATEGIC ALLIANCE AGREEMENT (this "AGREEMENT"), is made and entered into
effective as of February 27, 2006 between BRIDGETECH HOLDINGS INTERNATIONAL,
INC., a company incorporated in the State of Delaware, the United States of
American, with its principal office at 402 W. Broadway, 26th Floor, San Diego,
California 92101, U.S.A., ("BRIDGETECH"), and THE WU JIEPING MEDICAL FOUNDATION,
a non-profit-making organization under the Ministry of Health of the People's
Republic of China, with its registered address at No. 33 Dong Chang An Jie,
D4304 Beijing Hotel, Beijing, the People's Public of China ("WJPF").

BRIDGETECH and WJPF are referred to hereinafter jointly as the "PARTIES" and
individually as a "PARTY".

                                   WITNESSETH

     WHEREAS, WJPF is a foundation whose mission is to unite all medical
professionals inside and outside of China who share an interest in the
development of medicine and health, and to promote healthcare education in
China. This mission is to be furthered by the distribution of the latest
available medical drugs and equipments thereby serving the needs and enhancing
the well-being of the citizens of the Peoples Republic of China (the "PRC"), and
the wider world community;

     WHEREAS, BRIDGETECH is introducing world-class medical diagnostic and
therapeutic technologies to China for the purpose of maximizing the transfer of
healthcare technology. These technologies represent the latest scientific
discoveries and advances in medicine in the United States and Europe;

     WHEREAS, BRIDGETECH and WJPF wish to form a strategic alliance for the
distribution of the latest medical drugs and medical equipment to the people and
medical professionals of the PRC;

     NOW THEREFORE, in consideration of the premises and of the mutual covenants
and agreements contained in this Agreement, and for other good and valuable
consideration, the receipt and adequate of which is hereby acknowledged, the
Parties agree as follows.

1.   OBJECTIVE OF THE AGREEMENT

     The Parties agree that they shall, on the terms and conditions set forth in
     this agreement, cooperate in distributing BRIDGETECH's products in the PRC
     by adopting either trading or profit-sharing structure.

<PAGE>
2.   TERM

     The Parties agree that this Agreement shall have a cooperation term of ten
     (10) years, commencing from the date of this Agreement (the "TERM"). Upon
     expiration, the Term may be extended for an additional five (5) years terms
     (all such renewal terms shall be considered part of the Term), unless
     either Party notifies the other Party no later than sixty (60) days before
     the expiration of the Term that it does not wish to extent the Term.

3.   POWERS AND RESPONSIBILITIES OF THE PARTIES

     The Parties agree that they have the following powers and responsibilities
     under this Agreement:

3.1  WJPF shall:

     (i)       form a 100% owned subsidiary, or identify a company under its
               control (the "DESIGNATED DISTRIBUTOR"), with the approved scope
               of business of distributing medical drugs and equipments and
               provide a copy of the Designated Distributor's business license
               to BRIDGETECH before the execution of the distribution agreement
               as stipulated in Article 7 below;

     (ii)      have the first right of refusal to select from the list of
               Products (as defined below) for distribution in the PRC;

     (iii)     negotiate, enter into, and cause the Designated Distributor to
               enter into, a distribution agreement with BRIDGETECH in
               connection with each Product it has selected in accordance with
               the terms of this Agreement; and

     (iv)      participate as a member of BRIDGETECH's Scientific Advisory
               Board.

3.2  BRIDGETECH shall:

     (i)       review the qualifications of the Designated Distributor and
               approve the Designated Distributor;

     (ii)      supply a list of Products to WJPF on an on-going basis for its
               selection to be distributed in the PRC by the Designated
               Distributor;

     (iii)     negotiate and enter into a distribution agreement with WJPF and
               the Designated Distributor in connection with each Product that
               has been selected by WJPF in accordance with the terms of this
               Agreement.

2
<PAGE>
4.   LIST OF PRODUCTS

     Within ten (10) working days after receipt from WJPF a written notice that
     the Designated Distributor has been properly established or identified,
     BRIDGETECH shall provide to WJPF a list of initial BRIDGETECH's products,
     as amended from time to time, that are available for selection by WJPF for
     distribution in the PRC (the "PRODUCTS").

5.   SELECTION OF PRODUCTS

     WJPF shall decide which of the Products it wishes to distribute through the
     Designated Distributor in the PRC pursuant to the specific distribution
     agreements to be concluded in accordance with this Agreement and notify
     BRIDGETECH the Products in writing. The above-mentioned notice shall, in
     addition to the specific Product or Products, include the structure (either
     trading or profit-sharing structure) that WJPF and the Designated
     Distributor will adopt in distributing the Product.

6.   PROPOSED TERM SHEET

6.1  BRIDGETECH shall, within ten  (10) working days after receipt of the notice
     from WJPF as set forth in Article 5 above, provide WJPF with a proposed
     term sheet for the proposed distribution agreement for negotiation by the
     Parties.

6.2  The proposed term sheet shall contain ordinary commercial terms that are
     normally included in a distribution agreement, including, in particular,

     (i)       the nature of the appointment (exclusive or non-exclusive);

     (ii)      a proposed trading discount if WJPF elects to purchase the
               Product from BRIDGETECH for distribution purpose in the PRC; and

     (iii)     a proposed profit-sharing ratio if WJPF elects to provide
               services to third parties in cooperation with BRIDGETECH.

7.   DISTRIBUTION AGREEMENT ON PRODUCT BY PRODUCT BASIS

     The Parties agree that they will negotiate a separate distribution
     agreement for each Product that is selected by WJPF on the basis of the
     proposed term sheet offered by BRIDGETECH and reach a consensus regarding
     the terms and conditions and enter into a final distribution agreement for
     each of the Product selected by WJPF.

3
<PAGE>
8.   DISTRIBUTION OF COMPETITIVE PRODUCTS

     WJPF agrees that for those Products that WJPF and the Designated
     Distributor has entered into distribution agreements with BRIDGETECH, WJPF
     and the Designated Distributor shall not distribute any competitive
     product(s) for any third parties in the PRC.

9.   CONFIDENTIALITY

9.1  Prior to and during the process of finalizing this Agreement, each Party
     has disclosed or may disclosed confidential and proprietary information to
     the other Party. Each of the Parties receiving such information shall,
     during the Term and for three (3) years thereafter,

     (i)       maintain the confidentiality of such information; and

     (ii)      not disclose it to any person or entity, except to their
               employees who need to know such information to perform their
               responsibility.

9.2  The provisions of Article 9.1 above shall not apply to information that:

     (i)       can be shown to be known by the receiving Party's written records
               made prior to disclosure by the disclosing Party;

     (ii)      is or becomes public knowledge otherwise than through the
               receiving Party's breach of this Agreement; or

     (iii)     was obtained by the receiving Party from a third party having no
               obligations of confidentiality with respect to such information.

9.3  Each Party shall advise its directors, officers and other employees
     receiving such information of the existence of and the importance of
     complying with the obligations set forth in this Article 9.

9.4  Each of the Parties shall formulate rules and regulations to cause its
     directors, officers and other employees and those of their affiliates, also
     to company with the confidentiality obligation set forth in this Article 9.

9.5  Unless otherwise mutually agreed in writing by the Parties, this Article
     and the obligations and benefits hereunder shall survive for three (3)
     years after the expiration or early termination of this Agreement,
     notwithstanding the termination or rescission of this Agreement.

4
<PAGE>
10.  PRESS RELEASE AND ANNOUNCEMENTS

     BRIDGETECH and WJPF agree that no public release or announcement concerning
     this Agreement shall be issued or made by or on behalf of any Party without
     the prior consent of the other Party, except that either Party may, as
     required by the respective local law and policy, make announcements that
     such Party reasonably may determine are necessary to comply with applicable
     law. WJPF acknowledges and agrees that BRIDGETECH may be required to
     announce the terms of this Agreement and make publicly available this
     Agreement and that no breach of this Article 10 shall be deemed to result
     therefrom. Notwithstanding the foregoing, BRIDGETECH and WJPF shall
     cooperate to prepare a joint press release to be issued in connection with
     the entering into this Agreement.

11.  DISPUTE RESOLUTION.

11.1 In the event a dispute arises between the Parties in connection with the
     interpretation, implementation, performance, observance, breach or
     violation of the terms, provisions and conditions of this Agreement, the
     Parties shall attempt in the first instance to resolve such dispute through
     friendly consultations.

11.2 If the dispute is not resolved in this manner within thirty (30) days after
     one Party has served written notice on the other Party requesting
     commencement of such consultations, then either Party may submit the
     dispute to China International Economic and Trade Arbitration Commission
     ("CIETAC") in Beijing, the PRC for binding arbitration, which shall be
     conducted in accordance with CIETAC's arbitration rules in effect at the
     time of such submission for arbitration.

11.3 There shall be three (3) arbitrators.  The Parties agree that WJPF shall
     select one (1) arbitrator, BRIDGETECH shall select one (1) arbitrator and
     CIETAC shall select a person to be the third arbitrator.

11.4 The arbitration proceedings shall take place and be recorded in both
     English and Chinese.

11.5 The arbitration decision shall be final and binding on the Parties and the
     Parties agree to be bound thereby and to act accordingly.

11.6 The costs of the arbitration shall be borne by the Parties as decided in
     the arbitration award.

12.  MISCELLANEOUS PROVISIONS

12.1 This Agreement shall be binding on and inure to the benefit of the Parties
     and their respective successors and permitted assigns.

5
<PAGE>
12.2 This Agreement shall not be assigned in whole or in party by either Party
     without the prior written consent of the other Party.

     The provisions on assignment set forth in this Article 12.2, Paragraph 1
     shall not apply to any assignment by BRIDGETECH of its interest in this
     Agreement to any of its subsidiaries in China.

12.3 Each notice, communication and delivery under this Agreement (i) shall be
     made in writing signed by the Party making the same, (ii) shall specify the
     Article of this Agreement pursuant to which it is given, (iii) shall be
     given either in person or by telecopier, effective upon such delivery or
     the confirmed transmission and (iv) if not given in person, shall be sent
     to the applicable Party at the address set forth below (or at such other
     address as the applicable Party may furnish to the other Party pursuant to
     this subsection) by international courier delivery service, effective upon
     the second business day after such notice is deposited, delivery charges
     pre-paid, with such international courier delivery service. Each Party's
     notice information is as follows:

     BRIDGETECH:

     Bridgetech Holdings International, Inc.
     402 W. Broadway, 26th Floor
     San Diego, California 92101 USA
     Attn:  Thomas C. Kuhn III
     Phone:  678-428-3507
     Fax:  619-342-7497

     WITH A COPY TO:

     Sutherland Asbill & Brennan LLP
     999 Peachtree Street, NE
     Atlanta, Georgia 30309 USA
     Attn:  B. Knox Dobbins
     Phone:  404-853-8053
     Fax:  404-853-8806

     WJPF:

     The Wu Jieping Medical Foundation
     No. 33 Dong Chang An Jie
     D4304 Beijing Hotel
     Beijing, China 100004
     Attn: Dr. Fang Jun
     Phone:  010-65136624-85110136
     Fax:  010-85110192

6
<PAGE>
     Either Party may modify any information specified in this Article 12.3 by
     giving written notice to the other Party.

     All written communications made as provided in Article 12.3 shall be deemed
     given upon receipt by the Party to which it is addressed, which, in the
     case of facsimile, shall be deemed to occur by the close of the business
     day in the place of receipt on which the same is transmitted or such
     earlier time as is confirmed by the receiving Party.

12.4 The invalidity of any provision of this Agreement shall not affect the
     validity of any other provisions of this Agreement.

12.5 This Agreement shall only be amended upon the written agreement of each
     Party hereto. Failure or delay on the party of either Party hereto to
     exercise a right, power or privilege under this Agreement shall operate as
     a waiver thereof; nor shall any single or partial exercise of a right,
     power or privilege preclude any other future exercise thereof.

12.6 Except to the extent contemplated by this Agreement, nothing in this
     Agreement shall create or be deemed to create a partnership or STRATEGIC
     ALLIANCE between the Parties and except to the extent expressly specified
     in this Agreement no Party will or is entitled to act as agent for any
     other Party.

12.7 This Agreement shall be governed by the laws of the PRC which are published
     and publicly available, but in the event that there is no published and
     publicly available law in the PRC governing a particular matter relating to
     this Agreement, reference shall be made to general international commercial
     practices.

12.8 This Agreement shall be executed by the Parties in both English and
     Chinese.  Both versions shall be equally valid.

                            (Signature page follows.)

7
<PAGE>
IN WITNESS WHEREOF, the Parties have executed this Agreement on the date first
above written.

                                 BRIDGETECH HOLDINGS INTERNATIONAL, INC.

                                 By:

                                  /s/ Thomas C. Kuhn III
                                 -----------------------------------------------
                                 Name:        Thomas C. Kuhn III
                                 Position:    President and COO

                                 THE WU JIEPING MEDICAL FOUNDATION

                                 By:

                                   /s/ Fang  Jun
                                 -----------------------------------------------
                                 Name:        Fang Jun
                                 Position:    Secretary General

8EXHIBIT 10.19

                          STRATEGIC ALLIANCE AGREEMENT

     THIS STRATEGIC ALLIANCE AGREEMENT (this "AGREEMENT"), effective as of
October 19, 2005, is made by and between BRIDGETECH HOLDINGS INTERNATIONAL,
INC., a Delaware corporation ("BRIDGETECH"), and MCC Global Healthcare Group, a
Corporation ("MCCHG"), (MCCHG together with Bridgetech, the "PARTIES").

                                   WITNESSETH

     WHEREAS, MCCHG provides strategically driven excellence in business
development, financial, operational and globalization for client companies;

     WHEREAS, BRIDGETECH is leveraging its extensive relationships in China and
the U.S. to capitalize on proprietary opportunities in high growth segments of
the healthcare industry

     WHEREAS, the Parties wish to form a Strategic Alliance in order to leverage
geographical and market strengths for the introduction, regulatory approval, and
distribution of healthcare products and services globally;

     NOW THEREFORE, in consideration of the premises and of the mutual covenants
contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which is hereby acknowledged, the Parties agree as
follows.

     Definitions:

     ENTITY - a joint venture or other organizational structure as deemed
     appropriate by the Parties.

     PRODUCT - a drug, device or diagnostic.

     NET REVENUE - Gross Sales Revenue from a product, less direct cost of sales
     of that product and royalties established with third parties from whom the
     related Product was licensed.

1.   The Project.

     1.1  Each company will have a protected country or region where the
          proposed Strategic Alliance will not impact their current operations.
          Those will be as follows:

          (a)  BTHI - "Asia" - China, Hong Kong, Singapore, Philippines,
               Vietnam, Thailand, Laos, Burma, Indonesia, Australia, Korea,
               Taiwan, and Malaysia;

          (b)  MCC - "World" - Europe, USA, and South Africa.

     1.2  Each partner will create an Entity to pursue sales of Product in the
          other party's protected country or region. Opportunities may be
          introduced by one party and require the acceptance of the other party.
          All interests in these Entities will be shared 51% by the Entity Owner
          and 49% by the other partner.

     1.3  The two companies may create Entities in unprotected countries or
          regions for purposes of introducing Products. The Parties agree to use
          reasonable best efforts to establish a structure through which to
          handle these transactions.

2.   Assignment.

<PAGE>
     2.1  Bridgetech shall have the right to assign (with the written approval
          of MCCHG) this contract to one of its subsidiaries, or to an entity
          that Bridgetech creates, as needed to facilitate the distribution
          efforts in Asia;

3.   Term and Termination.

     3.1  Term. The Agreement will have an initial term of 10 years (the
          "PROJECT TERM"), at the end of which time the Project Term may be
          extended for additional 1 year terms (all such renewal terms shall be
          considered part of the "Project Term"), unless either Party notifies
          the other no later than 60 days before the end of the Project Term
          that it does not wish to extend the Project Term.

4.   Representations and Warranties.

     4.1  Representations and warranties of the Parties The Parties hereby
          represent and warrant as follows:

          (a)  Status. BRIDGETECH is a corporation validly existing and in good
               standing under the laws of the State of Delaware, U.S.A.
               BRIDGETECH has all necessary power to enter into this Agreement.

          (b)  Status. MCCHG is a Delaware corporation duly organized, validly
               existing and in good standing under the laws of Delaware. MCCHG
               has all necessary power to enter into this Agreement.

          (c)  Authorization, etc. The execution, delivery and performance by
               the Parties of this Agreement has been authorized by all
               necessary action on the part of such entity and its stockholders,
               as the case may be, and does not and will not

               (i)  violate the organizational documents of the Parties or any
                    applicable law, or

               (ii) contravene, conflict with, or result in a default under any
                    order or judgment of any court or other governmental
                    authority or any agreement to which the Parties may be
                    bound.

          (d)  Enforceability. Its obligations and the obligations of the
               Parties under this Agreement and any other agreement entered into
               by such entity in connection with this Agreement or the Project
               are and will be the legal, valid, and binding obligation of the
               Parties, enforceable against such entity in accordance with its
               terms, subject to applicable bankruptcy, reorganization,
               insolvency, moratorium, or similar laws affecting creditors'
               rights generally and subject as to enforceability, to equitable
               principle of general application regardless of whether
               enforcement is sought in a proceeding in equity or at law.

          (e)  Litigation. There are no suits, proceedings, judgments, rulings
               or orders by or before any governmental authority, court or
               arbitrator or any pending or threatened action or proceeding
               affecting the Parties before any governmental authority, court or
               arbitrator that could reasonably be expected to materially and
               adversely affect the financial condition or operations of the
               Parties or the ability of the Parties to perform their respective
               obligations under this Agreement or any other agreement entered
               into by such entity in connection with this Agreement or the
               Project, or which purports to affect the legality, validity or
               enforceability of this Agreement or any other such agreement.

                                        2
<PAGE>
5.   Confidential Information. For purposes of this Agreement "CONFIDENTIAL
     INFORMATION" means information provided by a Party to this Agreement (the
     "DISCLOSING PARTY") to any other Party to this Agreement (the "RESTRICTED
     PARTY") in connection with the transactions and relationships contemplated
     by the Project, including but not limited to:

          (a)  any data or information that is competitively sensitive material,
               and not generally known to the public, including, but not limited
               to, Product, planning information, marketing strategies, plans,
               finance operations, sales estimates, business plans, and internal
               performance results relating to the past, present or future
               business activities of the Disclosing Party and, services and
               Product provided to or obtained from, the terms of related
               contracts with, and the identities of any other identifying
               information regarding the customers, clients and suppliers of the
               Disclosing Party;

          (b)  any scientific or technical information, design, process,
               procedure, formula, or improvement that is commercially valuable
               and secret in the sense that its confidentiality affords the
               Disclosing Party a competitive advantage over its competitors;

          (c)  all confidential or proprietary concepts, documentation, reports,
               data (including magnetic tapes), specifications, web sites,
               screen formats, computer software, source code, object code, flow
               charts, databases, inventions, systems, system security features,
               system enhancements, information, know-how, show-how and trade
               secrets, whether or not patentable or copyrightable;

          (d)  all documents, inventions, substances, engineering and laboratory
               notebooks, drawings, diagrams, specifications, bills of material,
               equipment, prototypes and models, and any other tangible
               manifestation of the foregoing;

          (e)  any other information that a Disclosing Party treats as
               confidential information provided by an affiliate or other third
               party; and

          (f)  any information derived from any of the foregoing that is treated
               as confidential.

     Such Confidential Information shall not be disseminated or disclosed
     without prior consent by both Parties.

6.   Press Release and Announcements.

          The Parties agree that no public release or announcement concerning
     the transactions contemplated hereby shall be issued or made by or on
     behalf of any Party without the prior consent of the other Party, except
     that either Party may, after consultation with counsel, make announcements
     that such Party reasonably may determine are necessary to comply with
     applicable law. MCCHG acknowledges and agrees that BRIDGETECH may be
     required to announce the terms of this Agreement and make publicly
     available this Agreement and that no breach shall be deemed to result
     therefrom. Notwithstanding the foregoing, the Parties cooperate to prepare
     a joint press release to be issued in connection with the execution of this
     Agreement. The Parties further agree that each shall have the right to
     display the others logo on their respective websites.

                                        3
<PAGE>
                                   Section 1.

7.   Indemnification.

     7.1  Indemnification. Each Party (the "Indemnifying Party") will defend,
          indemnify, and hold the other Party, it officers and directors,
          shareholders, and each of its and their successors and permitted
          assigns (the "Indemnified Parties"), harmless from and against any and
          all liabilities, judgments, losses, actual damages, costs, and
          expenses (including without limitation reasonable attorneys' and
          experts' fees) which any or all of them may hereafter incur themselves
          or pay out to another by reason of any claim, suit, or proceeding
          brought by a third party, at law or in equity, that arises out of or
          relates to (i) a material breach of any representation, warranty,
          covenant, obligation or other provision of this Agreement by the
          Indemnifying Party or (ii) any other Event of Default, except to the
          extent caused by the gross negligence or willful misconduct of an
          Indemnified Party.

     7.2  Exclusion of Consequential Damages. NOTWITHSTANDING ANYTHING TO THE
          CONTRARY CONTAINED IN THIS AGREEMENT, NEITHER PARTY SHALL, UNDER ANY
          CIRCUMSTANCES, BE LIABLE TO THE OTHER PARTY FOR LOST PROFITS,
          CONSEQUENTIAL, INCIDENTAL, SPECIAL, PUNITIVE, OR INDIRECT DAMAGES
          ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS
          CONTEMPLATED HEREUNDER, EVEN IF THE PARTY HAS BEEN APPRISED OF THE
          LIKELIHOOD OF SUCH DAMAGES.

8.   Miscellaneous.

     8.1  Binding Effect. This Agreement shall be binding on and inure to the
          benefit of the Parties and their respective successors and permitted
          assigns.

     8.2  Assignment. This Agreement, except for as outlined in Section 2.1,
          shall not be assigned by either Party without the prior written
          consent of the other Party, not to be unreasonably delayed or
          withheld, and any purported such assignment without such consent shall
          be void. For purposes of this Section 8.2, a merger involving a Party
          shall be deemed to result in an assignment of this Agreement to the
          surviving entity in the merger, regardless of whether the Party is the
          surviving entity or merging entity to such merger.

     8.3  Notices and Other Communications.

          (a)  Each notice, communication and delivery under this Agreement (i)
               shall be made in writing signed by the Party making the same,
               (ii) shall specify the Section of this Agreement pursuant to
               which it is given, (iii) shall be given either in person or by
               telecopier, effective upon such delivery or the confirmed
               transmission and (iv) if not given in person, shall be sent to
               the applicable Party at the address set forth below (or at such
               other address as the applicable Party may furnish to the other
               Party pursuant to this subsection) by international courier
               delivery service, effective upon the second business day after
               such notice is deposited, delivery charges pre-paid, with such
               international courier delivery service. Each Party's notice
               information is as follows:

                                        4
<PAGE>
     BRIDGETECH: Bridgetech Holdings International, Inc.
                 777 S. Highway 101, Suite 215
                 Solana Beach, California 92075
                 Attn: Thomas C. Kuhn III
                 Phone: 619-342-7440
                 Fax: 619-342-7497

                 With a copy to:

                 Sutherland Asbill & Brennan LLP
                 999 Peachtree Street, NE
                 Atlanta, Georgia 30309
                 Attn: B. Knox Dobbins
                 Phone: 404-853-8053
                 Fax: 404-853-8806

     MCCHG:      MCC Healthcare Group
                 12813 Travers Trail
                 Ft. Worth, Texas 76248
                 Attn: Paul L. Rudisill
                 Phone: 801-898-1027
                 Fax: 817-887-2577

                 With a copy to:

                 Salt Lake City
                 11585 South State Street, Suite 102
                 Draper, Utah 84020
                 Phone: 801-816-2500
                 Fax: 801-816-2599

                 Attn: Kenneth Denos

     8.4  Severability. If any term or provision of this Agreement, or the
          application thereof to any person or circumstance, shall to any extent
          be contrary to any applicable law or regulation or otherwise invalid
          or unenforceable, the remainder of this Agreement or the application
          of such term or provision to persons or circumstances other than those
          as to which it is contrary, invalid or unenforceable shall not be
          affected thereby and, to the extent consistent with the overall intent
          of this Agreement taken as a whole, shall be enforced to the fullest
          extent permitted by applicable law and regulation.

     8.5  Governing Law. The Project Documents will be governed by the laws of
          Delaware except as specifically provided in such documents, without
          regard to principles of conflict of laws.

                                        5
<PAGE>
9.   Warrants.

     9.1  BTHI shall grant to MCCHG warrants to purchase shares of common stock
          in the future in the following schedule:

          A:   $1,500,000 @ $2.50 per share, expiring nine (9) months from the
               effective date of this agreement. If at any time during the term
               of these warrants, the closing market price of BTHI's common
               stock equals or exceeds $5.00, for five consecutive business
               days, then these warrants will immediately become due. In this
               instance, MCCHG will have 10 business days to exercise the
               warrants or they shall expire.

          B:   $1,000,000 @ $4.00 per share, expiring fifteen (15) months from
               the effective date of this agreement. If at any time during the
               term of these warrants, the closing market price of BTHI's common
               stock equals or exceeds $8.00, for five consecutive business
               days, then these warrants will immediately become due. In this
               instance, MCCHG will have 10 business days to exercise the
               warrants or they shall expire.

10.  Services.

     10.1 BTHI shall agree to work with MCCHG on the following areas:

          A:   BTHI will review MCCHG service offerings and select those that
               BTHI deems necessary to engage. Success fees will be paid on
               these selected services as agreed to under separate agreements
               between both parties.

          B:   BTHI agrees to consider moving to a listing on the AIM market. In
               the event that the AIM listing is pursued by BTHI, MCC's
               Securities will be the financial advisor. In the event other
               forms of capital is sought i.e. private, institutional, etc.
               MCC's Securities will be given the right to propose for such
               representation.

IN WITNESS WHEREOF, the Parties have executed this Agreement, or caused it to be
executed by their duly authorized officers or agents all as of the day and year
first above written.

                                        BRIDGETECH HOLDINGS INTERNATIONAL, INC.

                                        By: /s/ Thomas C. Kuhn III
                                            ------------------------------------
                                        Name: Thomas C. Kuhn III
                                        Title: EVP & CFO

                                        MCC HEALTHCARE GROUP

                                        By: /s/ Paul L. Rudisill
                                            ------------------------------------
                                        Name: Paul L. Rudisill
                                        Title: CEO

                                        6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]